HOME > TOP STORIES
TOP STORIES
-
BUSINESS Teijin Pharma Set to Transform Biz, Weather Feburic Patent Cliff with Takeda’s DPP-4s
April 8, 2021
-
BUSINESS Astellas Ended Scholarship Donation to Clear Up Doubts on Inducing Prescriptions, No Major Issues Seen after 1 Year
April 8, 2021
-
BUSINESS Takeda Sees FY2021 as Inflection Year for Pipeline, 4 Potential Approvals from 6 Submission-Planned Assets
April 7, 2021
-
BUSINESS AstraZeneca Looks to Become Top Drug Maker in Japan by 2025
April 7, 2021
-
REGULATORY AMED to Set Up Council to Hone Academic Seeds with Industry Input
April 7, 2021
-
BUSINESS Daiichi Sankyo Looks to Rack Up Sales of 1.6 Trillion Yen in FY2025, 3 ADCs as Drivers
April 6, 2021
-
REGULATORY MHLW to Consider Ways to Address Listing Delays Linked to Off-Year Re-Pricing: Official
April 6, 2021
-
REGULATORY Nichi-Iko’s Toyama Plant Gets Back Online as Suspension Order Lifted
April 6, 2021
-
REGULATORY Ex-PMDA Inspector Urges Improvements in Japanese Inspection Systems after GMP Scandals
April 5, 2021
-
BUSINESS Takeda/CSL-Led Alliance’s COVID-19 Plasma Therapy Fails in PIII
April 5, 2021
-
BUSINESS GSK Sees Promise in Antibody Therapy against Coronavirus Variants, Looking at Japan Rollout Too
April 2, 2021
-
BUSINESS Alinamin Aims for Growth via Retail Promotion, Full Entry into Asia: President
April 2, 2021
-
BUSINESS Sandoz Shooting for Top Foreign Player in Japan Generic Market by 2023
April 1, 2021
-
BUSINESS Japan Trials Get Underway for AstraZeneca’s COVID-19 Antibody Therapy
April 1, 2021
-
ORGANIZATION Generic Industry Group Requests Blanket Manufacturing Checkups for 39 Member Firms
March 31, 2021
-
BUSINESS Nafamostat Inhalation Drug Now in Clinic for COVID-19: Daiichi Sankyo
March 31, 2021
-
REGULATORY Japan Gives Up on Setting New Generic Target by March as Manufacturing Scandals Weigh
March 30, 2021
-
REGULATORY Japan to Wade Deeper into Generic Industry Revamp in New Pharma Vision, Due Out Summer
March 29, 2021
-
REGULATORY 35.6% of Pfizer Vaccine Recipients Developed Fevers after 2nd Shot, Higher Incidence in Women: MHLW
March 29, 2021
-
REGULATORY Nichi-Iko Starting Marketing Operations from March 29
March 29, 2021
ページ
On paper, things should be looking up for Japan’s pharmaceutical wholesalers. Industry expectations are mounting that the average gap between NHI and market prices will narrow further in FY2026 from the previous year’s record low of 4.8%.A shrinking gap should…
Tariffs have been a defining feature of US trade policy under President Donald Trump’s second administration. Since Trump unveiled his “reciprocal” tariff policy in April 2025, the landscape has shifted repeatedly.In February 2026, the US Supreme Court invalidated tariffs imposed…
